Home > News > Industry > Pharma News > HC asks Serum Institute,...

HC asks Serum Institute, Bharat Biotech to disclose Covid vaccines manufacturing capacity

By - Ruchika Sharma
Published On 2021-03-04 12:30 GMT   |   Update On 2021-03-04 12:30 GMT

New Delhi: The Delhi High Court Thursday directed Serum Institute of India and Bharat Biotech to disclose their capacities to manufacture Covaxin, Covishield vaccines. The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against Covid-19 currently as under the present system those above the age of...

Login or Register to read the full article
Register Now

New Delhi: The Delhi High Court Thursday directed Serum Institute of India and Bharat Biotech to disclose their capacities to manufacture Covaxin, Covishield vaccines.

The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against Covid-19 currently as under the present system those above the age of 60 years or between 45 to 60 years with comorbidities can receive the vaccination.

A bench of Justices Vipin Sanghi and Rekha Palli said the two institutes-- Serum Institute of India and Bharat Biotech -- have more capacity to provide the vaccines but it seems that they are not exploiting it fully.
"We are not utilising it fully. We are either donating it to foreign countries or selling it to foreign countries and are not vaccinating our own people. So there has to be that sense of responsibility and urgency," the bench said.
Read also: Data from 25,800 participants shows 81% efficacy of COVAXIN in Phase III trial: Bharat Biotech
It also asked the Delhi government to carry out inspection of medical facilities available in court complexes here and to report if Covid-19 vaccination centres could be set up there.
The high court was hearing a PIL initiated by it to examine the demand of Bar Council of Delhi to declare all people associated with the judicial functioning, including judges, court staff and lawyers as "frontline workers" so that they could receive Covid-19 vaccination on priority and without limitations of their age or physical condition.

Read also: COVID-19 recovered people showing faster antibody response to Serum Institute vaccine Covishield, says study



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Bayer, Evotec ink pact to advance precision cardiology
Janssen to adopt Johnson & Johnson brand in UK
Boehringer Ingelheim gets USFDA nod for high-concentration, citrate-free formulation of Cyltezo to treat multiple chronic inflammatory diseases
Labcorp gets USFDA nod for Companion Diagnostic for use with Pfizer hemophilia B Gene Therapy
Alkem Laboratories Gets CDSCO Panel Nod to Study Amoxicillin,Clavulanate Powder for reconstitution into suspension
Bharat Biotech Chief Dr Krishna M Ella named as new President of Indian Vaccine Manufacturers Association
Pneubevax 14 safe, immunogenic in 6-8 week old infants: Biological E
Sun Pharma served with tax demand of Rs 1.11 crore